Scientists at the Gladstone Institutes have discovered that the blood-brain barrier does more than prevent harmful substances from entering the brain. It also selectively transports beneficial proteins from the bloodstream, helping maintain healthy brain cells and neuronal connections. The discovery could offer a new direction for Alzheimer’s disease research by highlighting how communication between the brain and other organs influences neurological health.
Published in the journal Cell on November 11, 2026, the study identified 92 proteins that can cross the blood-brain barrier in mice. Researchers found that this transport system becomes disrupted in mouse models of early Alzheimer’s disease, preventing certain protective proteins from reaching the brain. When scientists increased levels of one of these proteins, APOA1, in the animals’ blood, they observed fewer Alzheimer’s-related disease markers.
Blood-Brain Barrier Is More Than a Protective Wall
The blood-brain barrier (BBB) is a specialized network of cells surrounding blood vessels in the brain. Its primary function is to regulate what can move between the bloodstream and brain tissue.
It protects the brain from many potentially harmful substances, including toxins and certain pathogens. It also controls the movement of nutrients and other molecules required for normal brain function.
For decades, scientists largely viewed the BBB as a protective wall that kept unwanted substances out. However, the new Gladstone research suggests that it also functions as an active delivery system, selecting specific proteins from the bloodstream and transporting them into the brain.
These proteins can originate in organs located far from the brain, particularly the liver.
The discovery adds another dimension to research into neurological diseases by suggesting that problems outside the brain could influence processes associated with Alzheimer’s.
Researchers Identify 92 Proteins That Cross Into the Brain
The research team, led by Gladstone investigator Andrew Yang, developed a technique to track proteins travelling from the bloodstream into the brain.
Scientists labelled a large collection of proteins in mouse blood and then examined brain tissue to determine which molecules had successfully crossed the blood-brain barrier.
Out of 861 proteins examined, 92 were found to enter the brain.
Most of these proteins were produced in distant organs, particularly the liver. Researchers also discovered that the BBB uses specialized receptors to recognize and transport selected proteins.
The findings suggest that the barrier acts as a molecular gatekeeper rather than a passive physical boundary.
| Research finding | Reported result |
|---|---|
| Proteins examined | 861 |
| Proteins found entering the brain | 92 |
| Main source of transported proteins | Distant organs, especially the liver |
| Main research focus | Blood-brain barrier protein transport |
| Study publication | November 11, 2026 |
| Scientific journal | Cell |
The researchers also found evidence that proteins are directed toward specific types of brain cells after crossing the barrier.
This selective delivery system could help explain how organs throughout the body communicate with the brain and influence its health.
APOA1 Emerges as an Important Protective Protein
Among the proteins identified in the study, researchers focused on apolipoprotein A1, commonly known as APOA1.
APOA1 is primarily produced in the liver and is also associated with high-density lipoprotein (HDL), often called good cholesterol.
Inside the brain, the protein appears to support the activity of astrocytes, specialized cells that help maintain the environment surrounding neurons.
The researchers found that APOA1 activates a pathway that encourages astrocytes to release cholesterol. This process is important because cholesterol helps maintain synapses, the connections through which neurons communicate.
Healthy synapses are essential for memory, learning and other cognitive functions.
The study also identified two receptors associated with APOA1 transport and activity: SR-B1 and ABCA1.
These receptors were found on cells of the blood-brain barrier and on astrocytes, helping researchers understand how APOA1 moves into the brain and influences its cells.
When scientists blocked ABCA1 in laboratory-grown astrocytes, APOA1 no longer produced the same cholesterol-regulating effects.
This provides evidence that the protein’s protective activity depends on specific molecular pathways.
Alzheimer’s Disease May Disrupt Protective Protein Transport Early
One of the study’s most important findings involved the timing of blood-brain barrier dysfunction.
Scientists have previously established that the barrier can become damaged as Alzheimer’s disease progresses. This breakdown can allow harmful substances to enter brain tissue.
However, the Gladstone team discovered that a different problem may occur earlier.
Using mice designed to model Alzheimer’s disease, researchers found that the blood-brain barrier began importing fewer protective proteins, including APOA1, before it physically started breaking down and becoming leaky.
This disruption was associated with:
- Reduced neuronal connections.
- Changes in animal behaviour.
- Disruption of protective protein pathways.
- Other early signs associated with Alzheimer’s disease.
The findings suggest that the loss of beneficial proteins could contribute to neurological dysfunction before the more widely recognized breakdown of the blood-brain barrier occurs.
This challenges the traditional view that BBB damage is primarily a consequence of advancing Alzheimer’s disease.
Instead, the researchers propose that the failure of its delivery function could be an earlier part of the disease process.
Increasing APOA1 Levels Reduced Alzheimer’s-Related Markers in Mice
After identifying APOA1 as a potentially protective protein, researchers investigated whether increasing its availability could improve outcomes in animals with Alzheimer’s-like disease.
They engineered mice to produce additional APOA1 in their livers.
This approach was designed to increase the amount of the protein circulating in the bloodstream and potentially entering the brain.
The results were encouraging.
As more APOA1 crossed the blood-brain barrier, the mice showed fewer Alzheimer’s-related markers. Researchers observed reduced fat accumulation in astrocytes and lower levels of inflammatory molecules.
The findings suggest that increasing the supply of certain beneficial proteins from organs such as the liver could become a possible strategy for protecting the brain.
However, these experiments were conducted in mice. They do not establish that increasing APOA1 would prevent, slow or treat Alzheimer’s disease in humans.
Further research will be needed to determine whether the same transport mechanisms operate in people and whether manipulating them can produce safe and meaningful clinical benefits.
Could the Discovery Lead to New Alzheimer’s Treatments?
The study opens several possible directions for future research.
One approach could involve increasing the production of protective proteins in organs outside the brain. If these proteins can cross the blood-brain barrier and reach the cells that need them, researchers may be able to influence neurological health without directly targeting brain tissue.
Another possibility involves using the BBB’s natural transport system to deliver medicines into specific brain cells.
Getting drugs across the blood-brain barrier has been a major challenge in neurological medicine. Many promising treatments struggle because the barrier prevents therapeutic molecules from reaching their intended targets.
Understanding how the brain naturally imports selected proteins could help researchers develop new delivery technologies.
Potential research applications include:
- Alzheimer’s research: Investigating whether restoring protective protein transport can reduce disease-related changes.
- Drug delivery: Developing systems that use BBB transport pathways to carry medicines into the brain.
- Brain health: Understanding how proteins produced by the liver and other organs influence neurological function.
- Neurodegenerative diseases: Exploring whether similar transport disruptions occur in other conditions affecting the brain.
These possibilities remain research directions rather than established treatments.
Why the Liver Could Play a Bigger Role in Brain Health
The study also highlights the importance of communication between different organs.
The liver produces numerous proteins that circulate through the bloodstream and perform functions throughout the body. Some of these molecules can cross the blood-brain barrier and influence brain cells.
This means neurological health may depend partly on biological processes taking place outside the nervous system.
The finding could encourage researchers to investigate how changes in liver function, circulating proteins and metabolic health influence brain ageing and neurodegenerative diseases.
It also supports a broader shift in neuroscience toward studying the brain as part of an interconnected biological system rather than treating it as an isolated organ.
The Bigger Picture
The Gladstone discovery could change how scientists investigate the early stages of Alzheimer’s disease. Rather than focusing exclusively on harmful substances accumulating inside the brain, researchers may also need to examine whether the brain is receiving enough of the beneficial molecules required to maintain healthy neurons.
The identification of 92 transported proteins provides an initial map of this biological delivery system. APOA1 offers one example of how a protein produced outside the brain can support the connections between neurons.
However, understanding the full system will require further experiments. Scientists must establish which proteins are most important, how their transport changes during human ageing and whether restoring these pathways can produce meaningful therapeutic effects.
Looking Ahead
Researchers at Gladstone are continuing to investigate the proteins transported across the blood-brain barrier and the mechanisms that direct them toward specific brain cells. Future studies will need to determine whether the early transport failures observed in Alzheimer’s mouse models also occur in humans. They will also need to establish whether increasing APOA1 or other protective proteins can safely influence disease progression.
For Alzheimer’s research, the findings introduce a potentially important new direction: treating neurological disease by restoring communication between the brain and the rest of the body. Although a human treatment remains far away, understanding the brain’s natural protein delivery system could eventually help scientists develop new therapies and more effective ways of delivering medicines across the blood-brain barrier.
SEO Title: Gladstone Study Finds Blood-Brain Barrier Blocks Protective Proteins in Alzheimer’s Mice
Meta Description: Gladstone researchers identified 92 proteins transported into the brain and found that Alzheimer’s mice lose access to protective proteins such as APOA1.
URL Slug: gladstone-study-blood-brain-barrier-alzheimers-protective-proteins
Focus Keyphrase: Blood-brain barrier Alzheimer’s study
Secondary Keywords: Gladstone Institutes research, APOA1 protein, Alzheimer’s disease research, blood-brain barrier, brain protein transport, liver and brain connection, neurodegenerative disease
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
